Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety, and tolerability of combination therapy with intramuscular
interferon beta-1a and oral doxycycline, a potent inhibitor of matrix metalloproteinases, in
patients with relapsing remitting multiple sclerosis (RRMS) having breakthrough disease
activity.
Phase:
Phase 4
Details
Lead Sponsor:
Louisiana State University Health Sciences Center Shreveport